Q-3 fatty acid supplement use in the 45 and Up Study Cohort

BMJ Open

Volumn 3, Issue 4, 2013, Pages

  Adams, Jon ^a   Sibbritt, David ^a   Lui, Chi Wai ^b   Broom, Alex ^b   Wardle, Jonathan ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; OMEGA 3 FATTY ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; DEPRESSION; DIET SUPPLEMENTATION; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; MALE; MARRIAGE; NEOPLASM; OSTEOARTHRITIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIVATE HEALTH INSURANCE; QUALITY OF LIFE; SEX DIFFERENCE; SMOKING;

EID: 84877680323     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002292     Document Type: Article

References (30)

1. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among USA adults has increased since NHANES III (1988-1994). NCHS Data Brief. Atlanta: Centers for Disease Control and Prevention, 2011:1-8.
2. Skeie G, Braaten T, Hjartåker A, et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr 2009;63:226-38.
3. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Hyattsville: U.S. Department of Health and Human Services, Division of Health Interview Statistics, Centers for Disease Control and Prevention, National Center for Health Statistics, 2008.
4. Brown J, Morgan T, Adams J, et al. Complementary medicines information use and needs of health professionals: general practitioners and pharmacists. Sydney: National Prescribing Service, 2008.
5. Chowdhury R, Stevens S, Gorman D, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-Analysis. BMJ 2012;345:e6698.
6. Filion KB, El Khoury F, Bielinski M, et al. Omega-3 fatty acids in high-risk cardiovascular patients: A meta-Analysis of randomized controlled trials. BMC Cardiovasc Disord 2010;10.
7. Kromhout D, Yasuda S, Geleijnse JM, et al. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 2012;33:436-43.
8. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-Analysis. JAMA 2012;308:1024-33.
9. National Heart Foundation of Australia. Position statement: fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Sydney: National Heart Foundation of Australia, 2008.
10. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: A systematic review. JAMA 2006;295:403-15. (Pubitemid 43144977)
11. Colomera R, Moreno-Nogueiraa JM, García-Lunaa PP, et al. N-3 fatty acids, cancer and cachexia: A systematic review of the literature. Br J Nutr 2007;97:823-31.
12. Lin P-Y, Su K-P. A meta-Analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of Omega-3 fatty acids. J Clin Psychiatry 2007;68:1056-61. (Pubitemid 47340326)
13. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev 2008;2:CD005169. doi: 10.1002/14651858.CD005169.pub2 (Pubitemid 351807388)
14. Thien FCK, De Luca S, Woods RK, et al. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2003;3:CD001283. doi: 10.1002/14651858.CD001283
15. Oliver C, Everard M, N'Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2007;4: CD002201.
16. Agency for Healthcare Research and Quality. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Rockville: Agency for Healthcare Research and Quality, 2004.
17. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012;6:CD005379. doi: 10.1002/14651858.CD005379.
18. James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011;11:CD007992. doi: 10.1002/14651858.CD007992.
19. Kickbusch I, Payne L. Twenty-first century health promotion: the public health revolution meets the wellness revolution. Health Promot Int 2003;18:275-8. (Pubitemid 38009702)
20. 45 and Up Study Collaborators. Cohort profile: the 45 and Up Study. Int J Epidemiol 2008;37:941-7.
21. Mealing N, Banks E, Jorm L, et al. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 2010;10.
22. Adams J, Sibbritt D, Easthope G, et al. The profile of women who consult alternative health practitioners in Australia. Med J Aust 2003;179:297-300. (Pubitemid 37150535)
23. Cockerham WC. Health lifestyles: bringing structure back. In: Cockerham WC, ed. The new Blackwell companion to medical sociology. Oxford: Wiley-Blackwell, 2009:159-83.
24. Wardle J, Lui C-W, Adams J. Complementary and alternative medicine in rural communities: current research and future directions. J Rural Health 2012;28:101-12.
25. Adams J, Sibbritt D, Lui C-W. The urban-rural divide in complementary and alternative medicine use: A longitudinal study of 10,638 women. BMC Complement Altern Med 2011;11:2.
26. Adams J. Exploring the interface between complementary and alternative medicine (CAM) and rural general practice: A call for research. Health Place 2004;10:285-87. (Pubitemid 38737302)
27. Sibbritt DW, Adams J, Young AF. A longitudinal analysis of mid-Age women's use of complementary and alternative medicine (CAM) in Australia, 1996-1998. Women Health 2004;40:41-56. (Pubitemid 40873366)
28. Broom A, Adams J. Oncology clinicians' accounts of discussing complementary and alternative medicine with their patients. Health 2009;13:317-36.
29. Wang C, Harris WS, Chung M, et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-And secondary-prevention studies: A systematic review. Am J Clin Nutr 2006;84:5-17. (Pubitemid 44699166)
30. Bishop FL, Yardley L, Lewith GT. Treat or treatment -A qualitative study analyzing patients' use of CAM. Am J Public Health 2008;98:1700-5.